OVERVIEW
A Cost of Illness (COI) model quantifies the total economic burden of a disease — direct medical costs, indirect costs such as productivity loss, and where relevant, informal care costs. COI evidence is used to frame the scale of unmet need, justify investment in a new therapy, and give payers and investors the context they need to act.
WHEN TO USE THIS MODEL
Is this the right model for you?
- Building the disease burden narrative ahead of launch
- Supporting market access strategy and HTA value dossiers
- Informing investor materials and commercial planning
- Demonstrating the economic case for earlier diagnosis or treatment
- Shaping health policy discussions and advocacy
WHAT WE DELIVER
What's included
Direct medical costs
hospitalisation, outpatient visits, medications, diagnostics, procedures
Indirect costs
productivity loss due to absenteeism, presenteeism, and early exit from workforce
Informal care costs
unpaid carer time and associated economic impact
Patient and carer quality of life impact
mapped to published utility values
Scenario modelling
current burden vs burden with improved treatment or diagnosis rates
Full technical report with data sources and methodology
PRICING
Fee tiers
TIER
FEE
TIMELINE
Single Market COI
Direct and indirect costs, one geography, full documentation
£8,000–15,000
3–5 weeks
Multi-Market COI
3–5 geographies with harmonised methodology and local adaptation
£25,000–40,000
8–12 weeks
All fees are fixed price. Scope, deliverables, and timeline are agreed before work begins. Additional market adaptations available — contact us for a tailored quote.